Fine-needle Aspiration Cytology of the Breast

REFERENCES

• Franzén S, Zajicek J. Aspiration biopsy in diagnosis of palpable lesions of the breast: critical review of 3479 consecutive biopsies. Acta Radiol Ther Phys Biol. 1968;7:241–262
   PubMedGoogle Scholar
• Franzen S, Giertz G, Zajicek J. Cytological diagnosis of prostatic tumours by transrectal aspiration biopsy: a preliminary report. Br J Urol. 1960;32:193–196.
   PubMedGoogle Scholar
• Wells CA, Ellis IO, Zakhour HD, Wilson AR. Editorial working party, cytology subgroup of the national coordinating commitee for breast cancer screening pathology. Guidelines for cytology procedures and reporting on fine needle aspirates of the breast. Cytopathology. 1994;5:316–334.
   PubMedGoogle Scholar
• Tabbara SO, Frost AR, Stoler MH, Sneige N, Sidawy MK. Changing trends in breast fine-needle aspiration: results of the Papanicolaou Society of Cytopathology Survey. Diagn Cytopathol. 2000;22:126–130.
   PubMedGoogle Scholar
• Berner A, Davidson B, Sigstad E, Risberg B. Fine-needle aspiration cytology vs. core biopsy in the diagnosis of breast lesions. Diagn Cytopathol. 2003;29:344–348.
   PubMedGoogle Scholar
• Simsir A, Rapkiewicz A, Cangiarella J. Current utilization of breast FNA in a cytology practice. Diagn Cytopathol. 2009:37:140–142.
   PubMed Web of Science ®Google Scholar
• Manfrin E, Mariotto R, Remo A. et al. Is there still a role for fine-needle aspiration cytology in breast cancer screening? Experience with real-time integrated radiopathologic activity. Cancer Cytopathol. 2008;114:74–82.
   Google Scholar
• Buchbinder SS, Gurell DS, Tarlow MM, Salvatore M, Suhrland MJ, Kader K, Role of US-guided fine-needle aspiration with on-site cytopathologic evaluation in management of nonpalpable breast lesions.
   Google Scholar
• Kocjan G. The role of breast FNAC in diagnosis and clinical management: a survey of current practice. Cytopathology. 2008;19 (5):271–278.
   PubMedGoogle Scholar
• Sauer T EK, Pedersen MK, Kåresen R. Liquid based material from fine needle aspirates from breast carcinomas offers the possibility of long-time storage without significant loss of immunoreactivity of estrogen and progesterone receptors. Cytojournal. 2010;7:24.
   PubMedGoogle Scholar
• Beraki E, Sauer T. Determination of HER-2 status on FNAC material from breast carcinomas using in situ hybridization with dual chromogen visualization with silver enhancement (dual SISH). Cytojournal. 2010;7:21.
   PubMedGoogle Scholar
• Ariga R, Bloom K, Reddy VB, et al. Fine-needle aspiration of clinically suspicious palpable breast masses with histopathologic correlation. Am J Surg. 2002;184:410–413.
   PubMed Web of Science ®Google Scholar
• Arisio R, Cuccorese C, Accinelli G, Mano MP, Bordon R, Fessia I. Role of fine-needle aspiration biopsy in breast lesions: analysis of a series of 4,110 cases. Diagn Cytopathol. 1998;18:462–467.
   PubMedGoogle Scholar
• Evans AT, Hussein AH. A microglandular adenosis-like lesion simulating tubular adenocarcinoma of the breast: a case report with cytological and histological appearances. Cytopathology. 1990;1 311–316.
   PubMedGoogle Scholar
• Layfield LJ, Dodd LG. Cytologically low grade malignacies: an important interpretative pitfall responsible for false negative diagnoses in fine-needle aspiration of the breast. Diagn Cytopathol. 1996;15 (3):250–259.
   PubMedGoogle Scholar
• Sauer T, Young K, Thoresen Sù. Fine needle aspiration cytology in the work-up of mammographic and ultrasonographic findings in breast cancer screening: an attempt at differentiating in situ and invasive carcinoma. Cytopathology. 2002;13(2):101–110.
   PubMedGoogle Scholar
• Jayaram G, Elsayed EM, Yaccob RB. Papillary breast lesions diagnosed on cytology: profile of 65 cases. Acta Cytol. 2007;51:3–8.
   PubMedGoogle Scholar
• Lui PC, Lau PP, Tse GM, Tan PH, et al. Fine needle aspiration cytology of invasive micropapillary carcinoma of the breast. Pathology. 2007;39:401–405.
   PubMed Web of Science ®Google Scholar
• Madur B, Shet T, Chinoy R. Cytologic findings in infiltrating micropapillary carcinoma and mucinous carcinomas with micropapillary pattern. Acta Cytol. 2007;51:25–32.
   PubMedGoogle Scholar
• Lopez-Ferrer P, Jimenez-Heffernan JA, Vicandi B, Ortega L, Viguer JM. Fine needle aspiration cytology of breast fibroadenoma: a cytohistologic correlation study of 405 cases. Acta Cytol. 1999;43:579–586.
   PubMedGoogle Scholar
• Orell SR. Radial scar/complex sclerosing lesion—a problem in the diagnostic work-up of screen-detected breast lesions. Cyopathology. 1999;10: 250–258.
   PubMedGoogle Scholar
• DeMay RM. The Art & Science of Cytopathology, vol. 2: Aspiration Cytology. Chicago: ASCP Press; 1996: 858–859.
   Google Scholar
• Bonzanini M, Gilioli E, Brancato B, et al. The cytopathology of ductal carcinoma in situ of the breast: a detailed analysis of fine needle aspiration cytology of 58 cases compared with 101 invasive ductal carcinomas. Cyopathology. 2001;12:107–119.
   PubMedGoogle Scholar
• Cangiarella J, Waisman J, Shapiro RL, Simsir A. Cytologic features of tubular adenocarcinoma of the breast by aspiration biopsy. Diagn Cytopathol. 2001;25:15–20.
   Google Scholar
• Karimzadeh M, Sauer T. Diagnostic accuray of fine-needle aspiration cytology in histological grade 1 carcinomas: are we good enough? Cytopathology. 2008;19:279–286.
   PubMedGoogle Scholar
• Sauer T, Young K, Thoresen S. Fine needle aspiration cytology in the work-up of mammographic and ultrasonographic findings in breast cancer screening: an attempt at differentiating in situ and invasive carcinoma. Cytopathology. 2002;13:101–110.
   PubMedGoogle Scholar
• Kumarasinghe MP, Poh WT. Differentiating non-high-grade duct carcinoma in situ from benign breast lesions. Diagn Cytopathol. 2004;30:98–102.
   PubMedGoogle Scholar
• Kollur SM, El Hag IA. FNA of breast fibroadenoma: observer variability and review of cytomorphology with cytohistological correlation Cyopathology. 2006;17:239–244.
   PubMedGoogle Scholar
• Bondeson L, Lindholm K. Apiration cytology of tubular breast carcinoma. Acta Cytol. 1990;34:15–20.
   PubMedGoogle Scholar
• Layfield, L. J. and L. G. Dodd. Cytologically low grade malignacies: an important interpretative pitfall responsible for false negative diagnoses in fine-needle aspiration of the breast. Diagn Cytopathol. 1996;15:250–259.
   PubMedGoogle Scholar
• Jayaram G, Elsayed EM, et al. Papillary breast lesions diagnosed on cytology: profile of 65 cases. Acta Cytol. 2007;51: 3–8.
   PubMedGoogle Scholar
• Simsir A, Waisman J, Thorner K, Cangiarella J. Mammary lesions diagnosed as “papillary” by aspiration biopsy: 70 cases with follow-up. Cancer. 2003;99:156–165.
   PubMed Web of Science ®Google Scholar
• Lui PC., Lau PP, et al. Fine needle aspiration cytology of invasive micropapillary carcinoma of the breast. Pathology. 2007;39:401–405.
   PubMed Web of Science ®Google Scholar
• Madur B, Shet T, et al. Cytologic findings in infiltrating micropapillary carcinoma and mucinous carcinomas with micropapillary pattern. Acta Cytol. 2007;51: 25–32.
   PubMedGoogle Scholar
• Shin HJ, Sneige N. Is a diagnosis of infiltrating versus in situ ductal carcinoma of the breast possible in fine-needle aspiration specimens? Cancer Cytopathol. 1998;84: 186–191.
   Google Scholar
• McKee GT, Tildsley G, Hammond S. Cytologic diagnosis and grading of ductal carcinoma in situ. Cancer Cytopathol. 1999;87:203–209.
   Google Scholar
• Chhieng DC, Fernandez G, Cangiarella JF, et al. Invasive carcinoma in clinically suspicious breast masses diagnosed as adenocarcinoma by fine-needle aspiration Cancer Cytopathol. 2000;90:97–101.
   Google Scholar
• Lee CH, Carter D, et al.. Ductal Carcinoma in situ diagnosed with stereotactic core needle biopsy: can invasion be predicted? Radiology. 2000;217: 466–70.
   PubMed Web of Science ®Google Scholar
• Sauer T, Lømo J, et al. Cytologic features of ductal carcinoma in situ in fine-needle aspiration of the breast mirror the histopathologic growth pattern heterogeneity and grading. Cancer Cytopathol. 2005;105: 21–27.
   Google Scholar
• Sauer T, Garred Ø, et al.. Assessing invasion criteria in fine needle aspirates from breast carcinoma diagnosed as DCIS or invasive carcinoma: can we identify an invasive component in addition to DCIS? Acta Cytol. 2006;50: 263–270.
   PubMedGoogle Scholar
• Bofin AM, Lydersen S, et al. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast. Diagn Cytopathol. 2004;31: 207–215.
   PubMedGoogle Scholar
• Bondeson L, Lindholm K. Prediction of invasiveness by aspiration cytology applied to nonpalpable breast carcinoma and tested in 300 cases. Diagn Cytopathol. 1997;17:315
   PubMedGoogle Scholar
• Pisano ED, Fajardo LL, Caudry DJ, et al. Fine-needle aspiration biopsy of nonpalpable breast lesions in a multicenter clinical trial: results from the radiologic diagnostic oncology group V. Radiology. 2001;219:785–792.
   PubMedGoogle Scholar
• Levine T. Breast cytology—is there still a role? Cytopathology. 2004;15:293–296.
   PubMedGoogle Scholar
• NHSBSP. Breast Screening Programme: Guidelines for Non-operative Diagnostic Procedures and Reporting in Breast Cancer Screening. NHS BSP Publication No. 50
   Google Scholar
• Lieske B, Ravichandran D, Wright D. Role of fine-needle aspiration cytology and core biopsy in the preoperative diagnosis of screen-detected breast carcinoma. Br J Cancer. 2006;95:62–66.
   PubMed Web of Science ®Google Scholar
• Krishnamurthy S. Applications of molecular techniques to fine-needle aspiration biopsy. Cancer Cytopathol. 2007;111:106–122.
   PubMed Web of Science ®Google Scholar
• Clark DP. Seize the opportunity. Cancer Cytopathol. 2009; 25;289–297.
   Google Scholar
• Sharma PS, Sharma R, Tyagi T. Receptor tyrosine kinase inhibitors as potent weapons in war against cancers. Curr Pharm Design. 2009;15:1–15.
   PubMedGoogle Scholar
• Wu JM, Fackler MJ, Halishka MK et al. Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases. Clin Cancer Res. 2008;14:1938–1946.
   PubMed Web of Science ®Google Scholar
• Garber K. Of ephs and ephrins: companies target guidance molecules in cancer. JNCI. 2010;22:1692–1694.
   Google Scholar
• Force T, Krause DS, Van Etten RA. Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition. Nature Rev. 2007;7:332–344.
   Google Scholar